These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4160866)

  • 1. Pseudomonas aeruginosa.
    Lancet; 1966 May; 1(7447):1139-40. PubMed ID: 4160866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunomodulation in Pseudomonas urinary infection].
    Urban M; Tamele L
    Rozhl Chir; 1995 Nov; 74(7):319-21. PubMed ID: 8629153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.
    Vincent JL
    Future Microbiol; 2014; 9(4):457-63. PubMed ID: 24810345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas pyocyanea infections in otorhinolaryngology].
    Nicoucar GR
    Pract Otorhinolaryngol (Basel); 1969; 31(6):359-64. PubMed ID: 4314671
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of respirator-associated infection due to Pseudomonas aeruginosa.
    Phillips I; King A; Jenkins S; Spencer G
    Lancet; 1974 Oct; 2(7885):871-3. PubMed ID: 4137591
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Prevention of the Pyocyaneus infections].
    Tanner F; Schäfer H; Jekić M; Andrasina J
    Hefte Unfallheilkd; 1973; 114():127-33. PubMed ID: 4205707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hospitalism caused by Pseudomonas aeruginosa].
    Schiek W
    Med Monatsschr; 1968 Apr; 22(4):163-7. PubMed ID: 4973237
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proceedings: II. Pyocyaneus infection. a. Prevention and therapy. Significance of Bacterium pyocyaneum (Ps. aeruginosa) from the bacteriologic viewpoint].
    Linzenmeier G
    Hefte Unfallheilkd; 1973; 114():123-7. PubMed ID: 4205706
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomonas aeruginosa in hospital.
    Constable FL; Thompson MW
    Lancet; 1973 Mar; 1(7805):721-2. PubMed ID: 4120518
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pseudomonas aeruginosa].
    Ono Y
    Nihon Rinsho; 2002 Nov; 60(11):2150-5. PubMed ID: 12440121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in immunization against Pseudomonas aeruginosa and Klebsiella spp.
    Cryz SJ
    Pathol Immunopathol Res; 1987; 6(2):147-52. PubMed ID: 3122194
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of pseudomonas respiratory infection in a surgical intensive care unit.
    Polk HC; Borden S; Aldrete JA
    Ann Surg; 1973 May; 177(5):607-15. PubMed ID: 4634109
    [No Abstract]   [Full Text] [Related]  

  • 13. Eradication of Pseudomonas aeruginosa infection from a special-care nursery.
    Drewett SE; Payne DJ; Tuke W; Verdon PE
    Lancet; 1972 Apr; 1(7757):946-8. PubMed ID: 4112107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa - typing methods and hospital infections].
    Bergan T
    Nord Med; 1968 Apr; 79(16):505-8. PubMed ID: 4968666
    [No Abstract]   [Full Text] [Related]  

  • 15. Infection and cross-infection in a new Burns Centre.
    Barclay TL; Dexter F
    Br J Surg; 1968 Mar; 55(3):197-202. PubMed ID: 4966047
    [No Abstract]   [Full Text] [Related]  

  • 16. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine.
    Pranter W; Staerk J; Zellner R; Zwisler O
    Prog Immunobiol Stand; 1971; 5():414-8. PubMed ID: 4633968
    [No Abstract]   [Full Text] [Related]  

  • 17. Of isolates and isolation: Pseudomonas aeruginosa in adults with cystic fibrosis.
    Geddes DM
    Lancet; 2001 Aug; 358(9281):522-3. PubMed ID: 11520516
    [No Abstract]   [Full Text] [Related]  

  • 18. [Various current problems in hospital hygiene].
    Grossmann G; Liebetrau B
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(1):1-9. PubMed ID: 102688
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infection control and prevention for multiple drug resistant pseudomonas aeruginosa].
    Maesaki S
    Nihon Geka Gakkai Zasshi; 2007 Sep; 108(5):274-8. PubMed ID: 17907458
    [No Abstract]   [Full Text] [Related]  

  • 20. Segregation and use of nonshared care settings reduce the risk of multiresistant P. aeruginosa infection. Re: Davies et al., "Multiresistant Pseudomonas aeruginosa in a pediatric cystic fibrosis center: natural history and implications for segregation," Pediatr Pulmonol 2003;35:253-256.
    Festini F; Ballarin S; Loganes C
    Pediatr Pulmonol; 2003 Aug; 36(2):171; author reply 172. PubMed ID: 12833499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.